Global Molecular Diagnostics in Infectious Disease Testing Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI12247009

Publication Date:

December 24, 2024

Pages:

108

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Molecular Diagnostics in Infectious Disease Testing market size was valued at US$ million in 2023. With growing demand in downstream market, the Molecular Diagnostics in Infectious Disease Testing is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Molecular Diagnostics in Infectious Disease Testing market. Molecular Diagnostics in Infectious Disease Testing are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Molecular Diagnostics in Infectious Disease Testing. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Molecular Diagnostics in Infectious Disease Testing market.
Molecular diagnostics is a technique used to detect the presence of and identify genetic materials and proteins associated with specific health conditions and diseases, and infectious agents in body fluids such as blood, urine, or sputum. Molecular diagnostics for infectious disease testing is used by hospitals, academics institutions, laboratories, and others. Increasing number of infectious diseases and technological advancement in diagnostic technologies for infectious diseases are some major driving factors for molecular diagnostics in the infectious disease testing market. Molecular diagnostics technologies are mainly used to diagnose diseases such as AIDS, tuberculosis (TB), hepatitis, and hospital-acquired infections.
North America has the largest market for molecular diagnostics in infectious disease testing, followed by Europe. This is due to technological advancement in molecular diagnostic tools, increasing prevalence of infectious diseases and improved healthcare infrastructure in the region. The market in Asia too, is expected to witness a high growth rate in the next few years. This is due to evolving research and development activities on infectious diseases, increasing government support, growing awareness among people about various infectious diseases and their diagnostic procedures, and improving healthcare infrastructure in the region. In addition, growing population and economies in developing countries, such as India and China, are expected to influence the growth in molecular diagnostics in infectious disease testing in Asia.
Key Features:
The report on Molecular Diagnostics in Infectious Disease Testing market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Molecular Diagnostics in Infectious Disease Testing market. It may include historical data, market segmentation by Type (e.g., Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT)), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Molecular Diagnostics in Infectious Disease Testing market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Molecular Diagnostics in Infectious Disease Testing market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Molecular Diagnostics in Infectious Disease Testing industry. This include advancements in Molecular Diagnostics in Infectious Disease Testing technology, Molecular Diagnostics in Infectious Disease Testing new entrants, Molecular Diagnostics in Infectious Disease Testing new investment, and other innovations that are shaping the future of Molecular Diagnostics in Infectious Disease Testing.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Molecular Diagnostics in Infectious Disease Testing market. It includes factors influencing customer ' purchasing decisions, preferences for Molecular Diagnostics in Infectious Disease Testing product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Molecular Diagnostics in Infectious Disease Testing market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Molecular Diagnostics in Infectious Disease Testing market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Molecular Diagnostics in Infectious Disease Testing market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Molecular Diagnostics in Infectious Disease Testing industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Molecular Diagnostics in Infectious Disease Testing market.
Market Segmentation:
Molecular Diagnostics in Infectious Disease Testing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Polymerase Chain Reaction (PCR)
Isothermal Nucleic Acid Amplification Technology (INAAT)
Microarrays
Next-Generation Sequencing (NGS)
Hybridization
Others
Segmentation by application
Hospitals
Clinics
Academic Institutes
Laboratories
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
BD
BioMerieux
Thermo Fisher Scientific
Roche
Siemens
Veridex
Luminex
GenMark Diagnostics
Qiagen
Genomix Biotech
BioTheranostics

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Molecular Diagnostics in Infectious Disease Testing Market Size 2019-2030
2.1.2 Molecular Diagnostics in Infectious Disease Testing Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Molecular Diagnostics in Infectious Disease Testing Segment by Type
2.2.1 Polymerase Chain Reaction (PCR)
2.2.2 Isothermal Nucleic Acid Amplification Technology (INAAT)
2.2.3 Microarrays
2.2.4 Next-Generation Sequencing (NGS)
2.2.5 Hybridization
2.2.6 Others
2.3 Molecular Diagnostics in Infectious Disease Testing Market Size by Type
2.3.1 Molecular Diagnostics in Infectious Disease Testing Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Molecular Diagnostics in Infectious Disease Testing Market Size Market Share by Type (2019-2024)
2.4 Molecular Diagnostics in Infectious Disease Testing Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Academic Institutes
2.4.4 Laboratories
2.4.5 Others
2.5 Molecular Diagnostics in Infectious Disease Testing Market Size by Application
2.5.1 Molecular Diagnostics in Infectious Disease Testing Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Molecular Diagnostics in Infectious Disease Testing Market Size Market Share by Application (2019-2024)
3 Molecular Diagnostics in Infectious Disease Testing Market Size by Player
3.1 Molecular Diagnostics in Infectious Disease Testing Market Size Market Share by Players
3.1.1 Global Molecular Diagnostics in Infectious Disease Testing Revenue by Players (2019-2024)
3.1.2 Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Players (2019-2024)
3.2 Global Molecular Diagnostics in Infectious Disease Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Molecular Diagnostics in Infectious Disease Testing by Regions
4.1 Molecular Diagnostics in Infectious Disease Testing Market Size by Regions (2019-2024)
4.2 Americas Molecular Diagnostics in Infectious Disease Testing Market Size Growth (2019-2024)
4.3 APAC Molecular Diagnostics in Infectious Disease Testing Market Size Growth (2019-2024)
4.4 Europe Molecular Diagnostics in Infectious Disease Testing Market Size Growth (2019-2024)
4.5 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size Growth (2019-2024)
5 Americas
5.1 Americas Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2019-2024)
5.2 Americas Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2019-2024)
5.3 Americas Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Molecular Diagnostics in Infectious Disease Testing Market Size by Region (2019-2024)
6.2 APAC Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2019-2024)
6.3 APAC Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Molecular Diagnostics in Infectious Disease Testing by Country (2019-2024)
7.2 Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2019-2024)
7.3 Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing by Region (2019-2024)
8.2 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2019-2024)
8.3 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Molecular Diagnostics in Infectious Disease Testing Market Forecast
10.1 Global Molecular Diagnostics in Infectious Disease Testing Forecast by Regions (2025-2030)
10.1.1 Global Molecular Diagnostics in Infectious Disease Testing Forecast by Regions (2025-2030)
10.1.2 Americas Molecular Diagnostics in Infectious Disease Testing Forecast
10.1.3 APAC Molecular Diagnostics in Infectious Disease Testing Forecast
10.1.4 Europe Molecular Diagnostics in Infectious Disease Testing Forecast
10.1.5 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Forecast
10.2 Americas Molecular Diagnostics in Infectious Disease Testing Forecast by Country (2025-2030)
10.2.1 United States Molecular Diagnostics in Infectious Disease Testing Market Forecast
10.2.2 Canada Molecular Diagnostics in Infectious Disease Testing Market Forecast
10.2.3 Mexico Molecular Diagnostics in Infectious Disease Testing Market Forecast
10.2.4 Brazil Molecular Diagnostics in Infectious Disease Testing Market Forecast
10.3 APAC Molecular Diagnostics in Infectious Disease Testing Forecast by Region (2025-2030)
10.3.1 China Molecular Diagnostics in Infectious Disease Testing Market Forecast
10.3.2 Japan Molecular Diagnostics in Infectious Disease Testing Market Forecast
10.3.3 Korea Molecular Diagnostics in Infectious Disease Testing Market Forecast
10.3.4 Southeast Asia Molecular Diagnostics in Infectious Disease Testing Market Forecast
10.3.5 India Molecular Diagnostics in Infectious Disease Testing Market Forecast
10.3.6 Australia Molecular Diagnostics in Infectious Disease Testing Market Forecast
10.4 Europe Molecular Diagnostics in Infectious Disease Testing Forecast by Country (2025-2030)
10.4.1 Germany Molecular Diagnostics in Infectious Disease Testing Market Forecast
10.4.2 France Molecular Diagnostics in Infectious Disease Testing Market Forecast
10.4.3 UK Molecular Diagnostics in Infectious Disease Testing Market Forecast
10.4.4 Italy Molecular Diagnostics in Infectious Disease Testing Market Forecast
10.4.5 Russia Molecular Diagnostics in Infectious Disease Testing Market Forecast
10.5 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Forecast by Region (2025-2030)
10.5.1 Egypt Molecular Diagnostics in Infectious Disease Testing Market Forecast
10.5.2 South Africa Molecular Diagnostics in Infectious Disease Testing Market Forecast
10.5.3 Israel Molecular Diagnostics in Infectious Disease Testing Market Forecast
10.5.4 Turkey Molecular Diagnostics in Infectious Disease Testing Market Forecast
10.5.5 GCC Countries Molecular Diagnostics in Infectious Disease Testing Market Forecast
10.6 Global Molecular Diagnostics in Infectious Disease Testing Forecast by Type (2025-2030)
10.7 Global Molecular Diagnostics in Infectious Disease Testing Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Abbott
11.1.1 Abbott Company Information
11.1.2 Abbott Molecular Diagnostics in Infectious Disease Testing Product Offered
11.1.3 Abbott Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Abbott Main Business Overview
11.1.5 Abbott Latest Developments
11.2 BD
11.2.1 BD Company Information
11.2.2 BD Molecular Diagnostics in Infectious Disease Testing Product Offered
11.2.3 BD Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 BD Main Business Overview
11.2.5 BD Latest Developments
11.3 BioMerieux
11.3.1 BioMerieux Company Information
11.3.2 BioMerieux Molecular Diagnostics in Infectious Disease Testing Product Offered
11.3.3 BioMerieux Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 BioMerieux Main Business Overview
11.3.5 BioMerieux Latest Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Information
11.4.2 Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Product Offered
11.4.3 Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Thermo Fisher Scientific Main Business Overview
11.4.5 Thermo Fisher Scientific Latest Developments
11.5 Roche
11.5.1 Roche Company Information
11.5.2 Roche Molecular Diagnostics in Infectious Disease Testing Product Offered
11.5.3 Roche Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Roche Main Business Overview
11.5.5 Roche Latest Developments
11.6 Siemens
11.6.1 Siemens Company Information
11.6.2 Siemens Molecular Diagnostics in Infectious Disease Testing Product Offered
11.6.3 Siemens Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Siemens Main Business Overview
11.6.5 Siemens Latest Developments
11.7 Veridex
11.7.1 Veridex Company Information
11.7.2 Veridex Molecular Diagnostics in Infectious Disease Testing Product Offered
11.7.3 Veridex Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Veridex Main Business Overview
11.7.5 Veridex Latest Developments
11.8 Luminex
11.8.1 Luminex Company Information
11.8.2 Luminex Molecular Diagnostics in Infectious Disease Testing Product Offered
11.8.3 Luminex Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Luminex Main Business Overview
11.8.5 Luminex Latest Developments
11.9 GenMark Diagnostics
11.9.1 GenMark Diagnostics Company Information
11.9.2 GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Product Offered
11.9.3 GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 GenMark Diagnostics Main Business Overview
11.9.5 GenMark Diagnostics Latest Developments
11.10 Qiagen
11.10.1 Qiagen Company Information
11.10.2 Qiagen Molecular Diagnostics in Infectious Disease Testing Product Offered
11.10.3 Qiagen Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Qiagen Main Business Overview
11.10.5 Qiagen Latest Developments
11.11 Genomix Biotech
11.11.1 Genomix Biotech Company Information
11.11.2 Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Product Offered
11.11.3 Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Genomix Biotech Main Business Overview
11.11.5 Genomix Biotech Latest Developments
11.12 BioTheranostics
11.12.1 BioTheranostics Company Information
11.12.2 BioTheranostics Molecular Diagnostics in Infectious Disease Testing Product Offered
11.12.3 BioTheranostics Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 BioTheranostics Main Business Overview
11.12.5 BioTheranostics Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂